Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)  Axel.

Slides:



Advertisements
Similar presentations
Plantar Flexion as an Alternative to Treadmill Exercise for Evaluating Patients with Intermittent Claudication K. Yamamoto, T. Miyata, A. Onozuka, H. Koyama,
Advertisements

Clinical leadership development in a pre-registration nursing curriculum: What the profession has to say about it Angela Brown, Patrick Crookes, Jan Dewing.
Ola Wallengren, Ingvar Bosaeus, Kent Lundholm  Clinical Nutrition 
Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306)  D.P. Modest, I. Ricard,
Breast Cancer Advocacy across Europe through the work and development of EUROPA DONNA, the European Breast Cancer Coalition  M. Buchanan, S. Kyriakides,
Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one.
European Journal of Cancer
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children.
Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell.
Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase.
Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma:
European Journal of Cancer
Rare cancers of the head and neck area in Europe
Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype  Romain Micol, MD, MPH, PhD, Lilia Ben Slama, PhD, Felipe Suarez, MD,
Volume 80, Issue 3, Pages (March 2009)
Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit  Pim J. van Leeuwen, David Connolly, Anna.
Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1–3 brain metastases: Results.
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating.
Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer  Philippe O. Gannon, Laurent Lessard, Louis-Mathieu.
Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)  M. Yoshida, K. Muro, A. Tsuji,
Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind.
Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – Results and treatment recommendations.
Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic.
Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: An.
Association between 11 genetic polymorphisms in folate-metabolising genes and head and neck cancer risk  Ana Lívia Silva Galbiatti, Lidia Maria Rebolho.
Volume 64, Pages e1-e3 (January 2017)
Volume 58, Issue 4, Pages (October 2010)
Irinotecan, Carboplatin, and Imatinib in Untreated Extensive-Stage Small-Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network 
Managing Metastatic Bone Pain: The Role of Bisphosphonates
Oral Vinorelbine and Cisplatin with Concurrent Radiotherapy After Induction Chemotherapy with Cisplatin and Docetaxel for Patients with Locally Advanced.
Volume 60, Issue 2, Pages (August 2011)
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria  M. Tazdait,
Managing Metastatic Bone Pain: The Role of Bisphosphonates
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Volume 65, Issue 5, Pages (May 2014)
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Volume 74, Issue 1, Pages (July 2018)
High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma 
Irinotecan, Carboplatin, and Imatinib in Untreated Extensive-Stage Small-Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network 
Hepatic resection of non-colorectal and non-neuroendocrine liver metastases – Survival benefit for patients with non-gastrointestinal primary cancers.
Volume 120, Issue 2, Pages (February 2001)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection
Volume 50, Issue 2, Pages (August 2006)
Adjuvant chemotherapy for rectal cancer – Authors' reply
Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype  Romain Micol, MD, MPH, PhD, Lilia Ben Slama, PhD, Felipe Suarez, MD,
Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy  Antoine Schernberg, Pierre Blanchard, Cyrus.
Psychological response and survival in breast cancer
Phase II Trial of Paclitaxel and Cisplatin in Patients with Extensive Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Trial 9430  Thomas E.
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Confessions of a journal junkie
European Urology is “Your” Journal
Volume 152, Issue 1, Pages (January 2019)
Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients?  Filipa Tavares, MD  Journal of Pain and Symptom.
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
Volume 130, Issue 1, Pages (July 2013)
Pathologic Complete Response to Preoperative Chemotherapy Predicts Cure in Early- Stage Non–Small-Cell Lung Cancer: Combined Analysis of Two IFCT Randomized.
Increasing incidence of brain tumours in sparsely populated areas
Oral Vinorelbine and Cisplatin with Concurrent Radiotherapy After Induction Chemotherapy with Cisplatin and Docetaxel for Patients with Locally Advanced.
Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.
Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View  Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,
New trials and results in systemic treatment of HCC
Table of contents The Journal for Nurse Practitioners
A Practical Tool to Identify Patients Who May Benefit from a Palliative Approach: The CARING Criteria  Stacy M. Fischer, MD, Wendolyn S. Gozansky, MD,
Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study  H Ismail,
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non- small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339) 
A Randomized Phase II Trial Assessing in Advanced Non-small Cell Lung Cancer Patients with Stable Disease after Two Courses of Cisplatin-Gemcitabine an.
Presentation transcript:

Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)  Axel Le Cesne, Jean-Yves Blay, Binh Nguyen Bui, Olivier Bouché, Antoine Adenis, Julien Domont, Angela Cioffi, Isabelle Ray-Coquard, Nathalie Lassau, Sylvie Bonvalot, Alain Moussy, Jean-Pierre Kinet, Olivier Hermine  European Journal of Cancer  Volume 46, Issue 8, Pages 1344-1351 (May 2010) DOI: 10.1016/j.ejca.2010.02.014 Copyright © 2010 Elsevier Ltd Terms and Conditions

Fig. 1 Kaplan–Meier analyses of progression-free survival (A) and overall survival (B). European Journal of Cancer 2010 46, 1344-1351DOI: (10.1016/j.ejca.2010.02.014) Copyright © 2010 Elsevier Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.